Skip to content

Examining the efficacy of online cognitive behaviour therapy with different levels of therapist support

A randomized trial examining the efficacy of online cognitive behaviour therapy with different levels of therapist support

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14230906
Enrollment
600
Registered
2016-04-21
Start date
2016-01-03
Completion date
Unknown
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Depression 2. Generalized Anxiety Disorder 3. Panic Disorder 4. Social Phobia Mental and Behavioural Disorders 1. Depression 2. Generalized Anxiety Disorder 3. Panic Disorder 4. Social Phobia

Interventions

Current interventions as of 28/11/2017: Transdiagnostic Internet-based CBT: The intervention is titled the Wellbeing Course (Dear. et al., 2011), which is a T-ICBT prog

Sponsors

University of Regina
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Resident of Saskatchewan and will be in Saskatchewan during the 8 week course period. 2. Aged 18 years or older, either sex 3. Experiencing symptoms of depression and/or anxiety 4. Has access to a computer and the Internet 5. Has a score of >4 on the Phq-9 or GAD-7 6. Has an interest in the Wellbeing Course

Exclusion criteria

Exclusion criteria: 1. Not a resident of Saskatchewan 2. Less than 18 years of age 3. Has no regular access to a computer, Internet, and use of printer 4. Currently receiving regular psychotherapy for depression or anxiety elsewhere or in some other form 5. Is unwilling to have their physician, a medical clinic, or an emergency hospital be notified of their participation in the program 6. High current risk of suicide or attempt in past year 7. Is experiencing unmanaged symptoms psychosis or mania 8. Alcohol or drug problem that requires primary treatment 9. Hospitalization for mental health problem in past year 10. Does not complete online or telephone screening 11. Does not consent to treatment or complete pre-treatment questionnaires

Design outcomes

Primary

MeasureTime frame
Primary outcome measures are administered at baseline (pre-treatment), before each lesson, immediately following completion of the program, and 3 months following completion of the program. 1. Depressive symptoms are measured using the Patient Health Questionnaire- 9 Item (PHQ-9). 2. Symptoms of generalized anxiety are measured using the Generalized Anxiety Disorder -7 Item (GAD-7)

Secondary

MeasureTime frame
Measured at baseline (pre-treatment), immediately following completion of the program, and 3 months following completion of the program. 1. Social phobia symptoms are measured using the Social Interaction Anxiety Scale 6-Item and Social Phobia Scale 6-Item Composite (SIAS6/SPS6) 2. Panic symptoms are measured by use of the Panic Disorder Severity Scale Self Rating (PDSS-SR) 3. Distress due to anxiety and depression symptoms is examined using the Kessler-10 (K-10) 4. The level of self perceived disability that is experienced by participants is measured using the Sheehan Disability Scales (SDS) 5. Health Service Utilization is determined using open-ended questions which ask participants to list the total number of visits to a variety of health professionals because of symptoms of anxiety or depression. Measured post-treatment and at 3-month follow-up 1. Working Alliance will be measured using the Working Alliance Inventory Short Revised (WAI-SR) 2. Participants satisfaction with treatment will be measured using the Treatment Satisfaction questions

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026